Inventor · disambiguated record
Kandhasamy Sarkunam
Also filed as: SARKUNAM KANDHASAMY
16 granted patents·19 citations·filing 2012–2021
87Inventor score
Top patents by PatentIndex Score
16 records- 0191US11713312B2Substituted bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 1, 2023·2 cites·14 claims
- 0290US12286428B2Tricyclic heteroaryl compounds useful as IRAK4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 29, 2025·2 cites·12 claims
- 0388US11254663B2Substituted bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 22, 2022·2 cites·26 claims
- 0481US9169252B2Heteroaryl substituted nicotinamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 27, 2015·5 cites·9 claims
- 0578US10202390B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 12, 2019·3 cites·12 claims
- 0675US8957203B2Hepatitis C virus inhibitorsHIEBERT SHELDON·Filed 2012·Granted Feb 17, 2015·4 cites·3 claims
- 0766US9527885B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 27, 2016·1 cites·8 claims
- 0852US12492186B2Bicyclic heterocyclic compounds useful as IRAK4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 9, 2025·0 cites·6 claims
- 0951US9643999B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 9, 2017·0 cites·16 claims
- 1051US9580463B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 28, 2017·0 cites·21 claims
- 1149US12319676B2Substituted amide compounds useful as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 3, 2025·0 cites·13 claims
- 1246US12227496B2Substituted bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 18, 2025·0 cites·11 claims
- 1346US12030835B2Substituted amide compounds useful as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 9, 2024·0 cites·15 claims
- 1440US9499550B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Nov 22, 2016·0 cites·18 claims
- 1535US10618903B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·10 claims
- 1633US8691757B2Hepatitis C virus inhibitorsRAJAMANI RAMKUMAR·Filed 2012·Granted Apr 8, 2014·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →